A Phase 3, Open-Label, Randomized Study of Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared With Venetoclax Plus Obinutuzumab in Patients With Previously Untreated Chronic Lymphocytic Leukemia

Project: Research

Project Details

StatusActive
Effective start/end date16/11/23 → 15/11/25

Keywords

  • Clinical trial
  • BGB-11417-301